52125-0744 Ondansetron - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

52125-0744

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

Injection

Administration Route:

Intramuscular

Intravenous

Substances:

Packages:

Code: 52125-0744-01

Description:

Effective Date: Dec. 17, 2013

Discontinued: Dec. 17, 2014

Code: 52125-0744-03

Description:

Effective Date: Nov. 25, 2013

Discontinued: Nov. 25, 2014

Code: 52125-0744-08

Description:

Effective Date: Jan. 6, 2014

Discontinued: April 14, 2016

Code: 52125-0744-14

Description:

Effective Date: Nov. 25, 2013

Discontinued: April 14, 2016

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

No Longer Used